Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Government Must Do More for Science Says New Research

Published: Friday, July 12, 2013
Last Updated: Friday, July 12, 2013
Bookmark and Share
The UK’s science-based economy needs greater support from the Government according to new research undertaken by Lab Innovations, the UK’s only event dedicated to the laboratory industries.

62% of directors and senior decision makers from over 112 scientific UK organisations say the UK Government isn’t doing enough to support them.

The list of government actions the companies call for include: greater investment to support key research projects, helping attract overseas investment in R&D, providing tax incentives for research, reducing taxes on manufacturing, science and technology companies and to allow more genuine foreign workers and students into the UK.

The 112 companies who participated in the survey cover the broad spectrum of science business sectors from biotech businesses, pharmaceutical companies, life science and environmental organisations through to research institutions plus healthcare, food, drink, chemical and petrochemical companies with extensive R&D teams.
The research suggests these science-based organisations are playing a crucial part of the UK economy.  For instance, 38% of those taking part employ over 100 people, with 17 companies employing over 500. The vast majority, (86%) are exporters, with on average 35% of sales going to overseas markets.  While two thirds of companies  are focused on selling into the EU and over a third (36%) to North America, many are pushing into vital emerging markets such as China (31%), India (21%) and Africa (16%).

According to the research, recent developments such as the weakness of sterling, have helped 16% to export more, however those surveyed are facing some major barriers which are inhibiting their success.  The biggest challenge is a lack of finance for R&D which is cited by 35%; a lack of finance for investment is also a major barrier afflicting 27%. Over one in five (23%) say too much red tape and regulation is holding them back, a similar number (22%) say growth is being inhibited by a lack of a skilled workforce.

While the Government has introduced initiatives to free up finance and talks about the importance of science, technology, engineering and mathematics (STEM), only 25% of the companies questioned believe the Government is genuine in its desire to rebalance the economy away from finance and services, and towards more STEM based activity.  Almost a third (31%) are unsure how serious the Government is with regards to this policy, and the largest group (44%) do not believe this is a genuine objective at all.

The companies studied face plenty of market opportunity, barely 6% say a lack of overseas demand is an issue, and few find it difficult to target overseas markets, but with almost one in five (19%) worried about even financing day-to-day activities, there is clearly an argument that greater finance is required if these important players in the UK economy are to reach their potential.

Commenting on the results of this survey, Jake Morrison, Lab Innovations event manager, says: “The UK has a tremendous scientific reputation, and the companies participating in the survey are thriving and extremely optimistic. Their mindset is on growth, and both within the UK and beyond.

“However there is clearly a lot of untapped potential within these companies which they want to unlock.  They are also highly dependent on R&D and future growth will only come from both research and expansion which requires investment.”

These will be just some of the topics debated on and around the show floor at this year’s Lab Innovations 2013 held at the NEC, Birmingham on the 6 & 7 November.  New for 2013, Lab Innovations will feature a dynamic panel debate hosted by The Royal Society of Chemistry giving industry experts and attendees to the show the opportunity to discuss the critical issues affecting the sector.

Lab Innovations 2013 will also feature over 100 exhibitors plus a conference programme featuring renowned keynote speakers and sessions organised by the Royal Society of Chemistry, plus practical workshops delivered by Campden BRI.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Launches and Innovation at LAB INNOVATIONS 2012
Supported by The Royal Society of Chemistry, LAB INNOVATIONS is the UK’s only event dedicated to showcasing the latest laboratory technology & consumables, analytical & biotech equipment.
Wednesday, July 25, 2012
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos